Oppenheimer Asset Management Inc. Myriad Genetics Inc Transaction History

Oppenheimer Asset Management Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$14.51 - $20.99 $121,506 - $175,770	-8,374 Reduced 17.2%	40,311 $584,000
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $30,847 - $47,228	1,694 Added 3.6%	48,685 $929,000
Q2 2022 Aug 08, 2022	SELL	$16.45 - $25.88 $49,119 - $77,277	-2,986 Reduced 5.97%	46,991 $854,000
Q1 2022 May 12, 2022	BUY	$22.67 - $28.01 $15,574 - $19,242	687 Added 1.39%	49,977 $1.26 Million
Q4 2021 Feb 02, 2022	SELL	$24.13 - $32.63 $32,068 - $43,365	-1,329 Reduced 2.63%	49,290 $1.36 Million
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $6,983 - $8,541	233 Added 0.46%	50,619 $1.63 Million
Q2 2021 Aug 03, 2021	SELL	$25.39 - $32.61 $286,475 - $367,938	-11,283 Reduced 18.3%	50,386 $1.54 Million
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $117,308 - $186,092	5,889 Added 10.56%	61,669 $1.88 Million
Q4 2020 Feb 11, 2021	BUY	$12.16 - $19.77 $107,810 - $175,280	8,866 Added 18.9%	55,780 $1.1 Million
Q3 2020 Nov 13, 2020	SELL	$11.25 - $14.75 $16,582 - $21,741	-1,474 Reduced 3.05%	46,914 $612,000
Q2 2020 Aug 11, 2020	SELL	$10.69 - $16.49 $13,672 - $21,090	-1,279 Reduced 2.58%	48,388 $549,000
Q1 2020 May 08, 2020	BUY	$9.78 - $29.53 $21,203 - $64,021	2,168 Added 4.56%	49,667 $711,000
Q4 2019 Feb 07, 2020	SELL	$20.93 - $35.1 $86,043 - $144,296	-4,111 Reduced 7.97%	47,499 $1.29 Million
Q3 2019 Oct 31, 2019	BUY	$22.08 - $47.08 $1.14 Million - $2.43 Million	51,610 New	51,610 $1.48 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.